Scientists probe bone marrow to unlock secrets of childhood leukemia
NCT ID NCT05792007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at bone marrow cells from children with acute leukemia and compares them to cells from children without blood diseases. The goal is to understand why some leukemias relapse or resist treatment. Researchers will measure how these cells use energy and handle stress, which may reveal new ways to fight the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal why some children's leukemia resists treatment, pointing toward new drug targets.
- What could go wrong
- This is an early observational study with only 40 participants, so findings may not apply broadly or lead directly to new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service d'hématologie biologique-CHRU TOURS
NOT_YET_RECRUITINGTours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Service d'onco-hématologie pédiatrique -CHRU Tours
RECRUITINGTours, 37044, France
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Service de chirurgie orthopédique pédiatrique -CHRU TOURS
RECRUITINGTours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a targeted drug plus donor immune cells fight back against relapsed leukemia?
- Can a Two-Drug combo outsmart a deadly leukemia?
- Can a new pill take on Hard-to-Treat leukemia?
- Leukemia drug cocktail aims to boost remission in High-Risk patients
- Could bone marrow from deceased donors cure blood cancers?